|

AZD5863 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • AstraZeneca1

Indications

  • Gastro-esophageal Junction Cancer1
  • Pancreatic Ductal Adenocarcinoma1
  • Esophageal Adenocarcinoma1
  • Gastric Cancer1
  • Cancer1

Jacksonville, Florida1 trial

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

Research Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.